Akihiro Nasu

1.1k total citations
44 papers, 758 citations indexed

About

Akihiro Nasu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Akihiro Nasu has authored 44 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hepatology, 28 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Akihiro Nasu's work include Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis C virus research (14 papers). Akihiro Nasu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis C virus research (14 papers). Akihiro Nasu collaborates with scholars based in Japan. Akihiro Nasu's co-authors include Yukio Osaki, Tōru Kimura, Ryuichi Kita, Hiroki Nishikawa, Azusa Sakamoto, Norihiro Nishijima, Sumio Saito, Haruhiko Takeda, Hideyuki Komekado and Keiichi Hatamaru and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Akihiro Nasu

43 papers receiving 748 citations

Peers

Akihiro Nasu
Akihiro Nasu
Citations per year, relative to Akihiro Nasu Akihiro Nasu (= 1×) peers Norihiro Nishijima

Countries citing papers authored by Akihiro Nasu

Since Specialization
Citations

This map shows the geographic impact of Akihiro Nasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Nasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Nasu more than expected).

Fields of papers citing papers by Akihiro Nasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Nasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Nasu. The network helps show where Akihiro Nasu may publish in the future.

Co-authorship network of co-authors of Akihiro Nasu

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Nasu. A scholar is included among the top collaborators of Akihiro Nasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Nasu. Akihiro Nasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamashina, Takeshi, Takanori Maruo, Hiroyuki Yoshida, et al.. (2018). Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter. SHILAP Revista de lepidopterología. 6(1). E111–E114. 20 indexed citations
2.
Nishikawa, Hiroki, Norihiro Nishijima, Hirayuki Enomoto, et al.. (2017). Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis. Journal of Cancer. 8(3). 378–387. 5 indexed citations
3.
Nishikawa, Hiroki, Norihiro Nishijima, Hirayuki Enomoto, et al.. (2017). Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir. Journal of Cancer. 8(2). 152–161. 27 indexed citations
4.
Nishikawa, Hiroki, Ryuichi Kita, Tōru Kimura, et al.. (2016). Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience. Molecular and Clinical Oncology. 4(4). 515–522. 2 indexed citations
5.
Nishikawa, Hiroki, Ryuichi Kita, Tōru Kimura, et al.. (2015). Hyponatremia in Hepatocellular Carcinoma Complicating with Cirrhosis. Journal of Cancer. 6(5). 482–489. 12 indexed citations
6.
Nishikawa, Hiroki, Ryuichi Kita, Tōru Kimura, et al.. (2015). Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis. Journal of Cancer. 6(4). 394–402. 19 indexed citations
7.
Nishikawa, Hiroki, Ryuichi Kita, Tōru Kimura, et al.. (2014). Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: Propensity score matching analysis. International Journal of Oncology. 45(3). 1082–1090. 4 indexed citations
8.
Nishikawa, Hiroki, Yukio Osaki, Hideyuki Komekado, et al.. (2014). Clinical implication of the preoperative GSA index in 99mTc-GSA scintigraphy in hepatitis C virus-related hepatocellular carcinoma. Oncology Reports. 33(3). 1071–1078. 5 indexed citations
9.
Nishikawa, Hiroki, Yukio Osaki, Hideyuki Komekado, et al.. (2014). Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection. Oncology Reports. 33(1). 88–94. 10 indexed citations
10.
Takeda, Haruhiko, Yukio Osaki, Azusa Sakamoto, et al.. (2013). A retrospective study of initial dose of sorafenib therapy in Japanese patients with unresectable hepatocellular carcinoma -experiences from a single center. Kanzo. 54(3). 169–177. 1 indexed citations
11.
Nishikawa, Hiroki, Yukio Osaki, Ryuichi Kita, et al.. (2013). Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma. Oncology Reports. 31(1). 65–72. 11 indexed citations
12.
Ueda, Yoshihide, Hiroyuki Marusawa, Tadashi Inuzuka, et al.. (2013). Dynamics of Defective Hepatitis C Virus Clones in Reinfected Liver Grafts in Liver Transplant Recipients: Ultradeep Sequencing Analysis. Journal of Clinical Microbiology. 51(11). 3645–3652. 14 indexed citations
13.
Nishikawa, Hiroki, Yukio Osaki, Eriko Iguchi, et al.. (2012). The Effect of Long-term Supplementation With Branched-chain Amino Acid Granules in Patients With Hepatitis C Virus-related Hepatocellular Carcinoma After Radiofrequency Thermal Ablation. Journal of Clinical Gastroenterology. 47(4). 359–366. 35 indexed citations
14.
Nishikawa, Hiroki, Yukio Osaki, Eriko Iguchi, et al.. (2012). Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine. 4(3). 381–386. 14 indexed citations
15.
Nishikawa, Hiroki, Eriko Iguchi, Azusa Sakamoto, et al.. (2012). Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib. Molecular and Clinical Oncology. 1(2). 241–248. 19 indexed citations
16.
Nishikawa, Hiroki, Yukio Osaki, Eriko Iguchi, et al.. (2012). Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes. Journal of Gastroenterology. 48(8). 951–965. 40 indexed citations
17.
Nishijima, Norihiro, Hiroyuki Marusawa, Yoshihide Ueda, et al.. (2012). Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing. PLoS ONE. 7(4). e35052–e35052. 69 indexed citations
18.
Nishikawa, Hiroki, Yukio Osaki, Ryuichi Kita, et al.. (2012). Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence. International Journal of Oncology. 41(3). 903–909. 24 indexed citations
19.
Nasu, Akihiro, Hiroyuki Marusawa, Yoshihide Ueda, et al.. (2011). Genetic Heterogeneity of Hepatitis C Virus in Association with Antiviral Therapy Determined by Ultra-Deep Sequencing. PLoS ONE. 6(9). e24907–e24907. 76 indexed citations
20.
Kita, Ryuichi, Norihiro Nishijima, Hisato Kawakami, et al.. (2007). Corona enhancement may emerge via sinusoidal drainage pathways. Kanzo. 48(5). 246–248. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026